Elizabeth Chappell

University of London

H指数:9

被引数:283

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

LATA（青少年长效治疗）试验的设计与入组特征：一项为期96周的随机、开放标签、非劣效性试验，评估在撒哈拉以南非洲12至<20岁病毒学抑制的HIV-1感染青少年中，与每日口服疗法相比，cabotegravir/rilpivirine双长效注射方案的病毒学疗效、安全性、可接受性和生活质量

Contemporary Clinical Trials

IF1.9

2026-03-010

PRE

Anena, Diana; Chappell, Elizabeth; Nazzinda, Rashidah; Kiilu, Cecilia; Chitsamatanga, Moses; Arumugam, Tiyara; Green, Alexandra; Mutuluuza, Cissy Kityo; Bwakura-Dangarembizi, Mutsa; Siika, Abraham; Archary, Moherndran; Jafta, Lungile; Namukwaya, Stella; Seeley, Janet; Akabwai, George; Mugerwa, Henry; Bevers, Lisanne; Burger, David; Walker, Simon; Bamford, Alasdair; South, Annabelle; Apoto, Naomi; Bush, Molly; Thomason, Margaret J.; Spittle, Ben; Ford, Deborah; Kekitiinwa, Adeodata R.; Pett, Sarah L.

Effectiveness and safety of tenofovir alafenamide fumarate–based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe

替诺福韦艾拉酚胺富马酸酯为基础的治疗与替诺福韦二吡呋酸富马酸酯和拉米夫定为基础的治疗相比，在居住于欧洲的HIV感染儿童及青少年中的有效性和安全性。

International Journal of Antimicrobial Agents

IF4.6

2025-09-260

OAAI

Pharmacokinetics of long-acting cabotegravir and rilpivirine in virologically suppressed adolescents living with HIV-1 in Sub-Saharan Africa: Data from the LATA trial

长效卡博格韦和 rilpivirine 在病毒学抑制的撒哈拉以南非洲 HIV-1 感染青少年中的药代动力学：来自 LATA 试验的数据

British Journal of Clinical Pharmacology

IF3

2025-09-030

PREAI

Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With Human Immunodeficiency Virus (HIV) on Dolutegravir in Europe and Thailand

病毒抑制、病毒学失败及安全性结局：欧洲和泰国人类免疫缺陷病毒（HIV）感染儿童和青少年使用Dolutegravir的研究

CLINICAL INFECTIOUS DISEASES

IF7.3

2025-07-010

OAAI

Scott, Karen; O'Rourke, John; Jackson, Charlotte; Ene, Luminita; Galli, Luisa; Goetghebuer, Tessa; Henegar, Cassidy; Koenigs, Christoph; Marczynska, Magdalena; Naver, Lars; Noguera-Julian, Antoni; Paioni, Paolo; Ramos, Jose T.; Smith, Birgitte; Songtaweesin, Wipaporn Natalie; Spoulou, Vana; Tantawarak, Nattakarn; Turkova, Anna; Vannappagari, Vani; Volokha, Alla; Bamford, Alastair; Castro, Hannah; Chappell, Elizabeth; Dalla Valle, Giorgia; Foster, Caroline; Guillen Martin, Sara; Prieto Tato, Luis Manuel; Puthanakit, Thanyawee; Sherstiuk, Halyna; Shkurka, Irina; Soeria-Atmadja, Sandra; Judd, Ali; Crichton, Siobhan; Collins, Intira Jeannie

Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine (vol 78, pg 937, 2023)

JOURNAL OF HEPATOLOGY

IF33

2024-02-010